Posted by Michael Wonder on 20 Apr 2024
Nora Pharma receives Health Canada approval for Niopeg, a biosimilar of Neulasta
19 April 2024 - Nora Pharma, a wholly owned division of Sunshine Biopharma, has received approval from Health Canada for the commercialisation of Niopeg (a pegylated form of filgrastim) in Canada.
Nora Pharma is a Canadian pharmaceutical company offering generic and specialty drugs across the country.
